RecruitingNot ApplicableNCT06935786

SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease

SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease. A Prospective Multicenter Follow-up Protocol With a Nested Randomized Controlled Trial of Physical Education Benefits - The SEDKID Study


Sponsor

Turku University Hospital

Enrollment

400 participants

Start Date

Feb 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to learn if a simple home exercise program can benefit patients with advanced chronic kidney disease. There is also an observational part of the study without an exercise program. The study will record patients' mortality, cardiovascular events, emergency department visits, hospital stays, need for dialysis and 6 minutes walking distance. Also maximal oxygen uptake, quality of life and bone fractures are recorded and blood tests and X-rays analyzed. The prospective observational part of the study will investigate the link between cardiovascular and kidney health as well as exercise capacity and adverse outcomes.


Eligibility

Min Age: 40 Years

Inclusion Criteria3

  • Age \>40 years
  • Estimated glomerular filtration rate \< 20ml/min/1.73m2 (CKD stage 4-5)
  • Informed consent from the patient is received

Exclusion Criteria5

  • Maintenance dialysis dependency before inclusion
  • Pregnant women
  • Patient's lack of commitment to follow-up
  • Chronic or acute clinical condition with a prognosis less than 6 months
  • Amputated lower limbs

Interventions

BEHAVIORALEXERCISE TRAINING WITH OR WITHOUT MEDICATION

Single appointment with a registered physiotherapist educating the patient for rehabilitating physical training and exercise to be performed independently and regularly by the patient at home, minimum of three times a week, during the study period.


Locations(3)

Satasairaala Hospital

Pori, Finland

Turku University Hospital

Turku, Finland

Vaasa Central Hospital

Vaasa, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06935786


Related Trials